<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04348734</url>
  </required_header>
  <id_info>
    <org_study_id>2015-A00993-46</org_study_id>
    <nct_id>NCT04348734</nct_id>
  </id_info>
  <brief_title>Management of Parapneumonic Pleurisy Guided by an Early Pleural Ultrasound</brief_title>
  <acronym>ECHOPP</acronym>
  <official_title>Management of Parapneumonic Pleurisy Guided by an Early Pleural Ultrasound</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Central Hospital Saint Quentin</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Amiens University Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Central Hospital Saint Quentin</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Parapneumonic pleurisies are a frequent complication of pneumopathies, but therapeutic
      management is poorly codified. Only the indication of thoracic drainage has benefited from
      expert recommendations. However, we find in the literature the major importance of early
      management of infectious pleurisy in order to minimize the sequelae. Pleural ultrasound,
      sensitive and specific in this pathology could bring us a real interest in terms of
      diagnostic speed and therefore of care. This study therefore seeks to show that pleural
      ultrasound can have a major interest in improving the management of patients with
      parapneumonic pleurisy, by reducing the number of medical treatment failures.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a prospective, multicentre, non-randomized study evaluating routine care, which
      includes all patients hospitalized in the departments participating in the study, for
      pneumonia with or without pleurisy. Patients benefiting from a daily pleural ultrasound for
      96 hours, D1 being the day of hospitalization. The therapeutic course of action will depend
      on the presence or not, and on the type of pleural effusion according to a pre-established
      algorithm. In case of pleural effusion of type 1, the type of treatment will be left to the
      appreciation of the clinician (puncture or drainage), in case of pleural effusion of type 2,
      3 or 4 the patient benefited from pleural drainage.

      Patients included in the study will benefit from a pleural ultrasound on the day of their
      hospitalization, up to 96 hours after treatment. Ultrasound will then allow us to look for
      the presence of pleural effusion. In the event of effusion corresponding to a parapneumonic
      effusion or purulent pleurisy, the conduct to be followed will be defined according to the
      ultrasound type of effusion. Types 1 will benefit from an evacuating pleural puncture or
      drainage, depending on the clinician's judgment. Types 2, 3, and 4 will benefit from weeping
      drainage.

      the target population: adult patients, hospitalized for pneumonia or confirmed pleurisy, by
      imaging and exploratory pleural puncture in the departments participating in the study over
      the period concerned The main outcome measure is the failure of medical treatment, defined as
      the need to resort to surgery, with or without peeling, or death secondary to pleurisy. The
      secondary endpoint is the presence of radiological sequelae at 3 months and 6 months defined
      by a retraction of the hemithorax concerned with pachypleuritis or an ascent of the
      diaphragmatic dome or the persistence of pleurisy
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">May 4, 2016</start_date>
  <completion_date type="Actual">May 4, 2020</completion_date>
  <primary_completion_date type="Actual">May 4, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>interet de l'échographie pleurale dans les pleurésies parapneumoniques</measure>
    <time_frame>1 year</time_frame>
    <description>Evaluate the failure of medical treatment, defined as the need to resort to surgery, or death secondary to pleuris</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>presence radiological sequelae a pleural effusion at 3 months</measure>
    <time_frame>3 months</time_frame>
    <description>the presence of radiological sequelae at 3 months defined by a retraction of the hemithorax concerned with pachypleuritis or an ascent of the diaphragmatic dome or the persistence of a pleural effusion</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>presence radiological sequelae a pleural effusion at 6 months</measure>
    <time_frame>6 months</time_frame>
    <description>the presence of radiological sequelae at 6 months defined by a retraction of the hemithorax concerned with pachypleuritis or an ascent of the diaphragmatic dome or the persistence of a pleural effusion</description>
  </secondary_outcome>
  <enrollment type="Actual">115</enrollment>
  <condition>Community-Acquired Infections</condition>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>pleural ultrasound</intervention_name>
    <description>Patients will benefit from a daily pleural ultrasound for 96 hours, D1 being the day of hospitalization. The therapeutic course of action will depend on the presence or not, and on the type of pleural effusion according to a pre-established algorithm</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        patients hospitalized for pneumonia
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  adult patients, hospitalized for pneumonia or confirmed pleurisy, by imaging and
             exploratory pleural puncture.

          -  Patients affiliated to social security

        Exclusion Criteria:

          -  patients with transudative pleurisy,

          -  patients with exudative pleurisy in the context of pulmonary neoplasia or
             tuberculosis,

          -  patients with pneumonectomy compartment infections,

          -  Patient under guardianship or curatorship,

          -  Subjects under 18 years of age,

          -  Pregnant women,

          -  patients in emergency situations
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>DOUADI Dr Youcef, ch</last_name>
    <role>Principal Investigator</role>
    <affiliation>CH Saint-Quentin</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Chu Amiens</name>
      <address>
        <city>Amiens</city>
        <zip>80000</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CH Pontoise</name>
      <address>
        <city>Cergy-Pontoise</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CH Creteil</name>
      <address>
        <city>Créteil</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Saint-Quentin Hospital</name>
      <address>
        <city>Saint-Quentin</city>
        <zip>02100</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <results_reference>
    <citation>Light RW. Pleural diseases. Curr Opin Pulm Med. 2003 Jul;9(4):251-3.</citation>
    <PMID>12806235</PMID>
  </results_reference>
  <results_reference>
    <citation>Miserocchi G. Physiology and pathophysiology of pleural fluid turnover. Eur Respir J. 1997 Jan;10(1):219-25. Review.</citation>
    <PMID>9032518</PMID>
  </results_reference>
  <results_reference>
    <citation>Davies CW, Gleeson FV, Davies RJ; Pleural Diseases Group, Standards of Care Committee, British Thoracic Society. BTS guidelines for the management of pleural infection. Thorax. 2003 May;58 Suppl 2:ii18-28.</citation>
    <PMID>12728147</PMID>
  </results_reference>
  <results_reference>
    <citation>Hamm H, Light RW. Parapneumonic effusion and empyema. Eur Respir J. 1997 May;10(5):1150-6. Review.</citation>
    <PMID>9163661</PMID>
  </results_reference>
  <results_reference>
    <citation>LeMense GP, Strange C, Sahn SA. Empyema thoracis. Therapeutic management and outcome. Chest. 1995 Jun;107(6):1532-7.</citation>
    <PMID>7781342</PMID>
  </results_reference>
  <results_reference>
    <citation>Bober K, Swietliński J. Diagnostic utility of ultrasonography for respiratory distress syndrome in neonates. Med Sci Monit. 2006 Oct;12(10):CR440-6. Epub 2006 Sep 25.</citation>
    <PMID>17006405</PMID>
  </results_reference>
  <results_reference>
    <citation>Soldati G, Sher S. Bedside lung ultrasound in critical care practice. Minerva Anestesiol. 2009 Sep;75(9):509-17. Review.</citation>
    <PMID>19644435</PMID>
  </results_reference>
  <results_reference>
    <citation>Ramnath RR, Heller RM, Ben-Ami T, Miller MA, Campbell P, Neblett WW 3rd, Holcomb GW, Hernanz-Schulman M. Implications of early sonographic evaluation of parapneumonic effusions in children with pneumonia. Pediatrics. 1998 Jan;101(1 Pt 1):68-71.</citation>
    <PMID>9417153</PMID>
  </results_reference>
  <results_reference>
    <citation>Xirouchaki N, Magkanas E, Vaporidi K, Kondili E, Plataki M, Patrianakos A, Akoumianaki E, Georgopoulos D. Lung ultrasound in critically ill patients: comparison with bedside chest radiography. Intensive Care Med. 2011 Sep;37(9):1488-93. doi: 10.1007/s00134-011-2317-y. Epub 2011 Aug 2.</citation>
    <PMID>21809107</PMID>
  </results_reference>
  <results_reference>
    <citation>Tokuda Y, Matsushima D, Stein GH, Miyagi S. Intrapleural fibrinolytic agents for empyema and complicated parapneumonic effusions: a meta-analysis. Chest. 2006 Mar;129(3):783-90.</citation>
    <PMID>16537882</PMID>
  </results_reference>
  <results_reference>
    <citation>Stavas J, vanSonnenberg E, Casola G, Wittich GR. Percutaneous drainage of infected and noninfected thoracic fluid collections. J Thorac Imaging. 1987 Jul;2(3):80-7.</citation>
    <PMID>3302292</PMID>
  </results_reference>
  <results_reference>
    <citation>Sahn SA. Management of complicated parapneumonic effusions. Am Rev Respir Dis. 1993 Sep;148(3):813-17. Review.</citation>
    <PMID>8368654</PMID>
  </results_reference>
  <results_reference>
    <citation>Taryle DA, Potts DE, Sahn SA. The incidence and clinical correlates of parapneumonic effusions in pneumococcal pneumonia. Chest. 1978 Aug;74(2):170-3.</citation>
    <PMID>679746</PMID>
  </results_reference>
  <results_reference>
    <citation>Pothula V, Krellenstein DJ. Early aggressive surgical management of parapneumonic empyemas. Chest. 1994 Mar;105(3):832-6.</citation>
    <PMID>8131548</PMID>
  </results_reference>
  <results_reference>
    <citation>Saito T, Kobayashi H, Kitamura S. Ultrasonographic approach to diagnosing chest wall tumors. Chest. 1988 Dec;94(6):1271-5.</citation>
    <PMID>3056662</PMID>
  </results_reference>
  <results_reference>
    <citation>Lichtenstein DA. BLUE-protocol and FALLS-protocol: two applications of lung ultrasound in the critically ill. Chest. 2015 Jun;147(6):1659-1670. doi: 10.1378/chest.14-1313. Review.</citation>
    <PMID>26033127</PMID>
  </results_reference>
  <results_reference>
    <citation>Lichtenstein DA, Menu Y. A bedside ultrasound sign ruling out pneumothorax in the critically ill. Lung sliding. Chest. 1995 Nov;108(5):1345-8.</citation>
    <PMID>7587439</PMID>
  </results_reference>
  <verification_date>March 2020</verification_date>
  <study_first_submitted>March 30, 2020</study_first_submitted>
  <study_first_submitted_qc>April 14, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">April 16, 2020</study_first_posted>
  <last_update_submitted>July 13, 2020</last_update_submitted>
  <last_update_submitted_qc>July 13, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">July 14, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Community-Acquired Infections</mesh_term>
    <mesh_term>Pleurisy</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>the data will be collected on an electronic Ecrf, a single extraction is planned by the protocol, all the collected data will be analyzed centrally by the study cordernator,no data sharing is planned in the study</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

